Versalus Health

Versalus Health, based in Newtown Square, US, is dedicated to enhancing healthcare revenue through innovative analytics and technology-driven solutions tailored for hospitals and health systems. Founded in 2016 by Joe Zebrowitz, Robert C, and Troy Williams, Versalus Health specializes in healthcare analytics and technology solutions. The company is headquartered in Newtown Square, US, and focuses on improving financial performance for healthcare providers. No significant pivots in business strategy have been noted.

Versalus Health offers a comprehensive suite of healthcare analytics and technology-driven solutions designed to enhance the financial performance of hospitals and health systems. Their core product offerings include Clinical Validation Technology®, PULSE Coding Automation Technology™, and REVIVE Specialized RCM Automation™, which collectively improve processes in clinical documentation integrity, coding, and accounts receivable recovery. Targeting challenges within the revenue cycle such as claim denials and operational efficiency, Versalus Health serves diverse clients in hospitals, health systems, and outpatient facilities across the United States, focusing on both fee-for-service and value-based care models. Versalus Health generates revenue through specialized healthcare services primarily via B2B engagements with hospitals and health systems.

The company operates on a subscription and partnership basis, where clients pay for access to their suite of technologies and consultancy services aimed at optimizing revenue cycle management. Specific services may include concurrent coding, clinical documentation audits, and accounts receivable management solutions. Due to the intricate nature of healthcare reimbursements, Versalus Health positions itself as a vital partner to ensure clients achieve financial resilience and operational efficiency. Versalus Health is strategizing the release of new products aimed at enhancing their existing technology suite, with specific details on release dates yet to be disclosed.

The company plans to expand into new markets, particularly targeting regions with high healthcare service demands. Recent funding will be utilized to support these initiatives, although further specifics are not available.